Autoimmune and inflammatory diseases

enfermedades autoinmunes artemisia annua

The therapeutic potential of artemisinin and its derivatives suggests the use of these components to treat autoimmune and inflammatory diseases in animals.

enfermedades autoinmunes artemisia annua

Various scientific studies and scientists suggest that artemisinin and/or its derivatives, in combination with other molecules, could have a positive influence in the treatment of diverse autoimmune and inflammatory diseases, such as multiple sclerosis, lupus nephritis, and rheumatoid arthritis, among other illnesses that might affect several animals.

What can artemisinin and its derivatives offer in these illnesses?

These active components possess the capacity to inhibit the proliferation and survival of self-reactive T-cells, and can effectively regulate the genes associated with inflammation and myelination, which are crucial factors in the pathology of multiple sclerosis as well.
Moreover, they have the ability to modulate inflammatory responses via inhibition of relevant pathways, namely the NF-κB – NLRP3 inflammasome pathway.